Jose “Pepe” Alvarez, Jr., M.D. Memorial Lecture on Vascular Disease: Critical Limb Ischemia Prevention and Control: The Road Ahead

Miami, FL US
October 10, 2017

One year after diagnosis of critical limb ischemia (CLI), 25% of patients have died, 30% are alive with amputations, 20% have ongoing symptoms and 25% have symptoms resolved. In managing CLI, the goals are pain relief and the restoration of skin integrity and function. With an estimated yearly incidence of 500 to 1000 new cases per million, CLI poses a substantial burden on patients, healthcare providers, and resources. Dr. Michael Jaff will assess current challenges in the management of CLI, as well as discuss opportunities to prevent other major complications that could impact patient care. 

 

In memory of Alan T. Hirsch, M.D., for his dedication and passion for vascular medicine.

image
July 17, 1954 - 
April 14, 2017

Alan T. Hirsch, M.D.
Professor of Medicine, Epidemiology
and Community Health
Director, Vascular Medicine, Quality
Outcomes and Population Health
Cardiovascular Division
University of Minnesota Medical School
Minneapolis, Minnesota

Much to our sadness and regret, the 11th Annual José “Pepe” Alvarez Jr., M.D., Memorial Lecture on Vascular Disease has been rescheduled to October due to the sudden death of Dr. Alan Hirsch, who was to be the guest lecturer. Dr. Hirsch was known worldwide for his efforts in the prevention and treatment of peripheral artery disease. He directed numerous clinical studies, including the landmark nationwide trial, the Claudication: Exercise vs. Endoluminal Revascularization (CLEVER) Study, which proved that a specific supervised exercise program could improve leg function and symptoms in those with PAD. Dr. Hirsch was a founder of the Society of Vascular Medicine. He died April 14 at the age of 62. Our sympathies go out to his loved ones, colleagues and patients.

 

Target Audience

Cardiologists, Vascular Surgeons,  Interventional Radiologists, Interventional Cardiologists, General Surgeons, Podiatrists, Primary Care Physicians, Emergency Medicine Physicians, General Internists, Nurses, Pharmacists, Respiratory Therapists, Radiology Technicians and other interested specialists.

 

LEARNING OBJECTIVES

  • Assess the diverse mechanisms that underpin the development of critical limb ischemia (CLI), and associated challenges in measuring syndrome incidence and prevalence.
  • Identify public health resources used to effectively prevent other major ischemic syndromes (AMI and stroke).
  • Distinguish the role of physicians, health professional societies, and public health agencies in achieving "CLI prevention and control."

Registration is required. Please log in to register.

Learning Objectives

 

 

      

Additional information
Schedule: 

Reception 6:00 p.m.

Lecture 6:30 p.m.

Adjourn 7:30 p.m.
 

Course Summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 General certificate of attendance
  • 1.00 Nurse Practitioners
  • 1.00 Florida Board of Nursing
  • 1.00 Florida Board of Occupational Therapy
  • 1.00 Florida Board of Pharmacy
  • 1.00 Florida Board of Podiatric Medicine
  • 1.00 Florida Bureau of Radiation Control
  • 1.00 Florida Board of Respiratory Therapy
Course opens: 
07/19/2017
Course expires: 
11/14/2017
Event starts: 
10/10/2017 - 6:00pm EDT
Event ends: 
10/10/2017 - 7:30pm EDT
Rating: 
0
Baptist Hospital
8900 N. Kendall Dr
5MCVI
Miami, FL 33176
United States

Michael R. Jaff, D.O.
President, Newton-Wellesley Hospital
Professor of Medicine, Harvard Medical School
Boston, Massachusetts 

Michael Jaff, D.O. has indicated he is a consultant for Micell and Phylips-Volcano, he is a stock shareholder for Embolitech, PQ Bypass, Vascular Therapies, non-compensated consultant for Abbott Vascular, Boston Scientific, Cordis, Medtronic, and is a board member of VIVA Physicians. His discussion will include off-label or unapproved product usage in their presentations or discussions.

Conference Directors and Planning Committee
James Benenati, M.D.
has indicated that he is a consultant for W.L. Gore, Cook and Penumbra.  He also has royalties with Penumbra. 
Barry T. Katzen, M.D. has indicated that he is a consultant for Boston Scientific, Philips Medical and W.L. Gore. 

Others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.

Non-faculty contributors and other individuals involved in the planning, development, review and editing of the symposium content have indicated neither they nor their spouses/partners have relevant financial relationships.

Disclosure Policy and Disclaimer

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 General certificate of attendance
  • 1.00 Nurse Practitioners
  • 1.00 Florida Board of Nursing
  • 1.00 Florida Board of Occupational Therapy
  • 1.00 Florida Board of Pharmacy
  • 1.00 Florida Board of Podiatric Medicine
  • 1.00 Florida Bureau of Radiation Control
  • 1.00 Florida Board of Respiratory Therapy
 
Status
Price
Title
$0.00Included
Please login or register for a Baptist Health CME account to take this course.
$0.00Included
Please login or register for a Baptist Health CME account to take this course.
Please login or register for a Baptist Health CME account to take this course.

Required Hardware/Software

Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to CME@BaptistHealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.